A61K 38 - Medicinal preparations containing peptides

Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
11/2006
11/09/2006	US20060252157 Larynx carcinoma-associated protein larcap-1
11/09/2006	US20060252129 Human coagulation Factor VII variants
11/09/2006	US20060252128 FVII OR FVIIa GLA DOMAIN VARIANTS
11/09/2006	US20060252127 Blood coagulation factor; nucleotide sequence encodes polypeptide; amino acid sequence differs in 1-15 amino acid residues and comprises an introduced in vivo N-glycosylation site; substitution V253N; coagulation related disorders
11/09/2006	US20060252125 ICE/CED-3 like protease designated FMH-1
11/09/2006	US20060252122 A tumor necrosis factor related ligand
11/09/2006	US20060252116 Icam-4 binding sites
11/09/2006	US20060252100 Can be used for the treatment of diabetes or for delaying the onset of diabetes
11/09/2006	US20060252037 Expression vector comprising antisense nuclelotide sequence which decrease exxpression from kinase suppressor of RAS (KRAS) for use in the treatment and prevention of cell proliferative disorders
11/09/2006	US20060252035 Using sphingosine kinase-2 as tool in identifying modulators for use in treatment of cell proliferative disorders
11/09/2006	US20060252029 Detection of hpv-induced invasive cancers and their precursor lesions with invasive potential
11/09/2006	US20060251735 Agents and methods for enhancing bone formation by oxysterols in combination with bone morphogenic proteins
11/09/2006	US20060251729 Tissue repair compositions and methods for their manufacture and use
11/09/2006	US20060251726 Bioactive FUS1 peptides and nanoparticle-polypeptide complexes
11/09/2006	US20060251725 Aggregation of particle sizes
11/09/2006	US20060251713 Amino acid sequences capable of facilitating penetration across a biological barrier
11/09/2006	US20060251712 Method and composition for hyperthermally treating cells
11/09/2006	US20060251708 Coenzyme q10 containing proliposome and preparation thereof
11/09/2006	US20060251699 Anti-angiogenic peptides from the N-terminus of endostatin
11/09/2006	US20060251681 Culturing a eukaryotic host cell transformed with a recombinant DNA construct including a Venezuelan equine encephalitis replicon vector, and at least one DNA fragment encoding any one of the Marburg virus proteins
11/09/2006	US20060251679 Protein or peptide capable of being fused to ferritin without interfering with the polymeric self-assembly of the resulting fusion protein; metal scavenging
11/09/2006	US20060251675 Mutant cholera holotoxin as an adjuvant and an antigen carrier protein
11/09/2006	US20060251669 Recombinant copper containing protein for use in prevention and treatment of parasitic infection
11/09/2006	US20060251663 Employment of rotavirus proteins, derived proteins and peptides for the modulation of tisssue permeability
11/09/2006	US20060251657 Treatment kit which assists with antibiotic therapy for intracellular infectious diseases
11/09/2006	US20060251650 Preventing angiogenesis by administering an antibody, or fragment, that specifically binds an extracellular domain of a neuropilin receptor; inhibiting endothelial growth factors (VEGF) from binding to the receptor; anticarcinogenic and antimetastasis agents
11/09/2006	US20060251649 Treatment of non-convulsive seizures in brain injury using G-2-methyl-prolyl glutamate
11/09/2006	US20060251648 Nucleotide sequences coding transport protein for use in identifying modulators for treatment of pain; flavor enhancement
11/09/2006	US20060251643 Regulatory zinc finger proteins
11/09/2006	US20060251642 Modulation of stem cells using zinc finger proteins
11/09/2006	US20060251641 Method and apparatus for treatment of cardiac disorders
11/09/2006	US20060251640 administering a D-amino acid oxidase which is chemically conjugated with a polymer, for accumulation in the tumor tissue, then administering D-amino acid which is a substrate for the D-amino acid oxidase, which releases reactive oxygen species; improved tumor selective cytotoxic activity results
11/09/2006	US20060251639 Recombinant copper containing protein for use in prevention and treatment of viral infection
11/09/2006	US20060251638 Cytoprotection through the use of hif hydroxylase inhibitors
11/09/2006	US20060251637 Oil-in-water type emulsion containing coenzyme q10 and process for producting the same
11/09/2006	US20060251635 Lactobacillus rhamnosus polynucleotides, polypeptides and methods for using them
11/09/2006	US20060251631 Treatment of joint disease, methods and apparatuses therefor
11/09/2006	US20060251629 Muscle-based grafts/implants
11/09/2006	US20060251627 Targeted vectors for cancer immunotherapy
11/09/2006	US20060251619 Modified interferon-gamma polypeptides and methods for using modified interferon-gamma polypeptides
11/09/2006	US20060251618 Implantable device for continuous delivery of interferon
11/09/2006	US20060251617 Methods for treating lymphomas
11/09/2006	US20060251616 Migration of hematopoietic stem cells and progenitor cells to the liver
11/09/2006	US20060251615 Therapeutic agent for preventing and/or treating sepsis
11/09/2006	US20060251612 Bioresorbable cyanoacrylate adhesives
11/09/2006	US20060251608 A Method of Treatment of Aging and Wrinkled Skin and a Kit Containing Compositions for Same
11/09/2006	US20060251604 Method for diagnosing alopecia
11/09/2006	DE102005015832A1 Use of receptor multimerization epitope (RME) of advanced glycation end product receptor (AGER) as immunogen, useful for preparing antibodies for diagnosis and treatment of e.g. spinal injuries or diabetic complications
11/09/2006	CA2609561A1 Polypeptide, vaccine and use thereof
11/09/2006	CA2607777A1 Transdermal absorption enhancer
11/09/2006	CA2607575A1 Mutations in oas1 genes
11/09/2006	CA2607483A1 Peptides and peptide mimetics to treat pathologies characterized by an inflammatory response
11/09/2006	CA2607341A1 Diagnosis and treatment of endometriosis
11/09/2006	CA2607276A1 Sclerostin fragments and anti-sclerostin antibodies
11/09/2006	CA2607155A1 Pharmaceutical compositions comprising casein derived peptides and methods of use thereof
11/09/2006	CA2607150A1 Glucagon-like-peptide-2 (glp-2) analogues
11/09/2006	CA2606989A1 Vascular targeting of ocular neovascularization
11/09/2006	CA2606962A1 Assays for diagnosis of tuberculosis and uses thereof
11/09/2006	CA2606688A1 Phospholipid formulations and uses thereof in lung disease detection and treatment
11/09/2006	CA2606668A1 Antiviral peptide against hepatitis c virus
11/09/2006	CA2606515A1 Method of improving learning and memory in mammals
11/09/2006	CA2606479A1 Nogo receptor functional motifs and peptide mimetics related thereto and methods of using the same
11/09/2006	CA2606341A1 Genemap of the human genes associated with crohn's disease
11/09/2006	CA2606195A1 Hcv ns3 protease inhibitors
11/09/2006	CA2606177A1 Novel polypeptide and use thereof
11/09/2006	CA2606162A1 Peptide having antianxiety activity and screening method therefor
11/09/2006	CA2605863A1 Cell-surface decoration with active agents
11/09/2006	CA2604180A1 Vegf variants
11/09/2006	CA2603020A1 Ejection liquid, ejection method, method for forming liquid droplets, liquid ejection cartridge and ejection apparatus
11/08/2006	EP1719780A2 Mammalian cytokine-like polypeptide-10
11/08/2006	EP1719779A2 Antibodies against Matin
11/08/2006	EP1719773A1 Fused heterotetracyclic compounds and use tehreof as hcv polymerase inhibitor
11/08/2006	EP1719543A1 Use of histone deacetylase inhibitors for the treatment of gastrointestinal distress
11/08/2006	EP1719527A1 Antitumor agent
11/08/2006	EP1719526A2 Pharmaceutical combinations comprising a P2T receptor antagonist and another anti-thrombotic agent
11/08/2006	EP1719523A1 Protein drug sustained-release microparticle preparation for injection and process for producing the same
11/08/2006	EP1719522A1 Medicinal composition comprising TCF-II
11/08/2006	EP1719521A1 Preventive and/or remedy for retinopathy
11/08/2006	EP1719520A1 Antigen epitopes of the regulatory protein of virulence factor in staphylococcus aureus and their mimotopes and use
11/08/2006	EP1719508A1 Use of histone deacetylase inhibitors for the prevention or treatment of joint destruction
11/08/2006	EP1719505A2 Pharmaceutical formulations for dry powder inhalers in the form of hard pellets
11/08/2006	EP1718767A2 Compositions and methods for characterizing, regulating, diagnosing, and treating cancer
11/08/2006	EP1718762A1 Antisense oligonucleotide modulation of stat3 expression
11/08/2006	EP1718747A2 Stabilized rnas as transfection controls and silencing reagents
11/08/2006	EP1718746A1 Induction of apoptosis by inhibition of sirtuin sirt1 expression
11/08/2006	EP1718742A1 Fungall cell wall degrading enzyme
11/08/2006	EP1718740A2 Methods for obtaining thermostable enzymes, dna polymerase i variants from thermus aquaticus having new catalytic activities, methods for obtaining the same, and applications to the same
11/08/2006	EP1718674A2 Membrane attack complexes associated with circulating immune complexes
11/08/2006	EP1718673A1 Albumin-purification method comprising a nanofiltration step, solution, and composition for therapeutic use containing same
11/08/2006	EP1718672A1 Crystal structures and models for fc receptors and uses thereof in the design or identification of fc receptor modulator compounds
11/08/2006	EP1718671A2 Peptide yy analogues
11/08/2006	EP1718670A1 Il-15 binding site for il 15-ralpha and specific il-15 mutants having agonist/antagonist activity
11/08/2006	EP1718667A2 Heterocyclic self-immolative linkers and conjugates
11/08/2006	EP1718665A2 Hybrid polypeptides with selectable properties
11/08/2006	EP1718664A2 Modified human four helical bundle polypeptides and their uses
11/08/2006	EP1718662A2 Multiplex detection probes
11/08/2006	EP1718659A1 Vectors having both isoforms of beta-hexosaminidase and uses of the same
11/08/2006	EP1718639A2 Caspase inhibitors and uses thereof
11/08/2006	EP1718339A2 Modified human interferon polypeptides and their uses
11/08/2006	EP1718334A2 Methods of diagnosing and treating pre-eclampsia or eclampsia

1 ... 1186 1187 1188 1189 1190 1191 1192 1193 1194 1195 1196 1197 1198 1199 1200 1201 1202 1203 1204 1205 1206 ... 3163